[go: up one dir, main page]

EP1660970A4 - SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS - Google Patents

SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS

Info

Publication number
EP1660970A4
EP1660970A4 EP04779720A EP04779720A EP1660970A4 EP 1660970 A4 EP1660970 A4 EP 1660970A4 EP 04779720 A EP04779720 A EP 04779720A EP 04779720 A EP04779720 A EP 04779720A EP 1660970 A4 EP1660970 A4 EP 1660970A4
Authority
EP
European Patent Office
Prior art keywords
systems
methods
biopolymers
engineering
engineering biopolymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04779720A
Other languages
German (de)
French (fr)
Other versions
EP1660970A2 (en
Inventor
Claes Gustafsson
Sridhar Govindarajan
Jeremy Stephen Minshull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DNA Twopointo Inc
Original Assignee
DNA Twopointo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DNA Twopointo Inc filed Critical DNA Twopointo Inc
Priority to EP08003668A priority Critical patent/EP1939779A3/en
Priority to EP11161151A priority patent/EP2434420A3/en
Publication of EP1660970A2 publication Critical patent/EP1660970A2/en
Publication of EP1660970A4 publication Critical patent/EP1660970A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • C07K16/11—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/20—Protein or domain folding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Databases & Information Systems (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Medicinal Chemistry (AREA)
  • Artificial Intelligence (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
EP04779720A 2003-08-01 2004-07-30 SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS Withdrawn EP1660970A4 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08003668A EP1939779A3 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering
EP11161151A EP2434420A3 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49181503P 2003-08-01 2003-08-01
US53635704P 2004-01-14 2004-01-14
US53686204P 2004-01-15 2004-01-15
PCT/US2004/024752 WO2005013090A2 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP08003668A Division EP1939779A3 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering

Publications (2)

Publication Number Publication Date
EP1660970A2 EP1660970A2 (en) 2006-05-31
EP1660970A4 true EP1660970A4 (en) 2007-02-14

Family

ID=34119818

Family Applications (2)

Application Number Title Priority Date Filing Date
EP04779720A Withdrawn EP1660970A4 (en) 2003-08-01 2004-07-30 SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS
EP11161151A Withdrawn EP2434420A3 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP11161151A Withdrawn EP2434420A3 (en) 2003-08-01 2004-07-30 Systems and methods for biopolymer engineering

Country Status (3)

Country Link
US (3) US20080050357A1 (en)
EP (2) EP1660970A4 (en)
WO (2) WO2005013090A2 (en)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188231B2 (en) 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
US7317091B2 (en) 2002-03-01 2008-01-08 Xencor, Inc. Optimized Fc variants
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US8093357B2 (en) 2002-03-01 2012-01-10 Xencor, Inc. Optimized Fc variants and methods for their generation
US20090010920A1 (en) 2003-03-03 2009-01-08 Xencor, Inc. Fc Variants Having Decreased Affinity for FcyRIIb
US8388955B2 (en) 2003-03-03 2013-03-05 Xencor, Inc. Fc variants
US8084582B2 (en) 2003-03-03 2011-12-27 Xencor, Inc. Optimized anti-CD20 monoclonal antibodies having Fc variants
US9051373B2 (en) 2003-05-02 2015-06-09 Xencor, Inc. Optimized Fc variants
US8005620B2 (en) 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
EP1660970A4 (en) 2003-08-01 2007-02-14 Dna Twopointo Inc SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS
US8101720B2 (en) 2004-10-21 2012-01-24 Xencor, Inc. Immunoglobulin insertions, deletions and substitutions
US9714282B2 (en) 2003-09-26 2017-07-25 Xencor, Inc. Optimized Fc variants and methods for their generation
EP1737890A2 (en) 2004-03-24 2007-01-03 Xencor, Inc. Immunoglobulin variants outside the fc region
US20150010550A1 (en) 2004-07-15 2015-01-08 Xencor, Inc. OPTIMIZED Fc VARIANTS
US8802820B2 (en) 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
US8367805B2 (en) 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
US8546543B2 (en) 2004-11-12 2013-10-01 Xencor, Inc. Fc variants that extend antibody half-life
AU2005304624B2 (en) 2004-11-12 2010-10-07 Xencor, Inc. Fc variants with altered binding to FcRn
WO2007041635A2 (en) 2005-10-03 2007-04-12 Xencor, Inc. Fc variants with optimized fc receptor binding properties
US7973136B2 (en) 2005-10-06 2011-07-05 Xencor, Inc. Optimized anti-CD30 antibodies
US8524867B2 (en) 2006-08-14 2013-09-03 Xencor, Inc. Optimized antibodies that target CD19
AU2007299843B2 (en) 2006-09-18 2012-03-08 Xencor, Inc Optimized antibodies that target HM1.24
US20090118130A1 (en) 2007-02-12 2009-05-07 Codexis, Inc. Structure-activity relationships
DE102007011912A1 (en) * 2007-03-13 2008-09-18 Sanofi-Aventis Method for generating peptide libraries and their use
DK2808343T3 (en) 2007-12-26 2019-08-19 Xencor Inc Fc variants with altered binding to FcRn
US12492253B1 (en) 2008-02-25 2025-12-09 Xencor, Inc. Anti-human C5 antibodies
US20110160071A1 (en) * 2008-06-03 2011-06-30 Baynes Brian M Novel Proteins and Methods for Designing the Same
US8401798B2 (en) 2008-06-06 2013-03-19 Dna Twopointo, Inc. Systems and methods for constructing frequency lookup tables for expression systems
US7561973B1 (en) 2008-07-31 2009-07-14 Dna Twopointo, Inc. Methods for determining properties that affect an expression property value of polynucleotides in an expression system
US7561972B1 (en) 2008-06-06 2009-07-14 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
US8126653B2 (en) 2008-07-31 2012-02-28 Dna Twopointo, Inc. Synthetic nucleic acids for expression of encoded proteins
JP2011527579A (en) * 2008-07-08 2011-11-04 アボット・ラボラトリーズ Prostaglandin E2 binding protein and use thereof
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
WO2011091078A2 (en) 2010-01-19 2011-07-28 Xencor, Inc. Antibody fc variants with enhanced complement activity
US20140297397A1 (en) * 2010-04-25 2014-10-02 Tomer Bakalash Use of neural activation in the superior temporal sulcus as a predictor for memorability of audio and/or visual content and emotional engagement
KR20120052683A (en) * 2010-11-16 2012-05-24 한국전자통신연구원 Context sharing apparatus and method for providing intelligent service
CN102199575B (en) * 2011-03-16 2013-04-03 中国检验检疫科学研究院 Corn chlorotic mottle virus monoclonal antibody and application thereof
EP2742065B1 (en) * 2011-08-12 2017-08-02 E.R.D.E.-aak-Diagnostik Gmbh Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia
US20130252280A1 (en) * 2012-03-07 2013-09-26 Genformatic, Llc Method and apparatus for identification of biomolecules
CN102870534B (en) * 2012-09-21 2014-09-17 浙江大学 Genetic algorithm based automatic bowl transporting route optimization method of plug seedlings
CN102854289B (en) * 2012-10-11 2015-03-25 云南烟草科学研究院 Method for predicting release amount of phenol in mainstream smoke of flue-cured tobaccos
US20140207267A1 (en) * 2013-01-23 2014-07-24 Hewlett-Packard Development Company, L.P. Metric based on estimate value
US10438581B2 (en) 2013-07-31 2019-10-08 Google Llc Speech recognition using neural networks
WO2015164723A1 (en) 2014-04-25 2015-10-29 The Trustees Of The University Of Pennsylvania Methods and compositions for treating metastatic breast cancer and other cancers in the brain
DK3142750T3 (en) 2014-05-13 2020-09-14 Univ Pennsylvania COMPOSITIONS INCLUDING AAV EXPRESSING DUAL ANTIBODY CONSTRUCTIONS AND USES THEREOF
CN104262484A (en) * 2014-10-17 2015-01-07 深圳出入境检验检疫局动植物检验检疫技术中心 Specific IgY antibody for resisting African swine fever virus as well as preparation method and application thereof
WO2016200543A2 (en) 2015-05-13 2016-12-15 The Trustees Of The University Of Pennsylvania Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
EP4316512A3 (en) 2015-10-28 2024-04-24 The Trustees of The University of Pennsylvania Intrathecal administration of adeno-associated-viral vectors for gene therapy
AU2017248659B2 (en) 2016-04-15 2022-08-11 The Trustees Of The University Of Pennsylvania Gene therapy for treating hemophilia A
US11191847B2 (en) 2016-04-15 2021-12-07 The Trustees Of The University Of Pennsylvania Gene therapy for treating hemophilia B
CN107688853B (en) * 2016-08-05 2020-01-10 中科寒武纪科技股份有限公司 Device and method for executing neural network operation
US20180144370A1 (en) * 2016-11-22 2018-05-24 Conversant, Llc Signal based ecpm prediction and bidding
MX2019007873A (en) 2016-12-30 2019-11-18 Univ Pennsylvania GENE THERAPY TO TREAT WILSON'S DISEASE.
KR102738752B1 (en) 2016-12-30 2024-12-06 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Gene therapy to treat phenylketonuria
JP2020506705A (en) 2017-02-01 2020-03-05 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Gene therapy to treat citrullinemia
JOP20190200A1 (en) 2017-02-28 2019-08-27 Univ Pennsylvania Compositions useful in treatment of spinal muscular atrophy
SI3589730T1 (en) 2017-02-28 2024-04-30 The Trustees Of The University Of Pennsylvania Adeno-associated virus (aav) clade f vector and uses therefor
WO2018160573A1 (en) 2017-02-28 2018-09-07 The Trustees Of The University Of Pennsylvania Influenza vaccines based on aav vectors
CA3054136A1 (en) 2017-03-01 2018-09-07 The Trustees Of The University Of Pennsylvania Gene therapy for ocular disorders
US11879133B2 (en) 2017-04-24 2024-01-23 The Trustees Of The University Of Pennsylvania Gene therapy for ocular disorders
SG10201912401QA (en) 2017-05-11 2020-02-27 Univ Pennsylvania Gene therapy for neuronal ceroid lipofuscinoses
CA3098592A1 (en) 2017-05-31 2018-12-06 The Trustees Of The University Of Pennsylvania Gene therapy for treating peroxisomal disorders
CN117050176A (en) * 2017-07-31 2023-11-14 豪夫迈·罗氏有限公司 Humanization method based on three-dimensional structure
CN108168678B (en) * 2017-11-22 2019-12-24 河南中烟工业有限责任公司 A Dynamic Data Processing Method for Weighing Rod Cigarette Package Missing Detection
US11629198B2 (en) 2017-12-05 2023-04-18 The Trustees Of The University Of Pennsylvania Fusion proteins and antibodies targeting human red blood cell antigens
CN108102924B (en) * 2018-01-12 2021-06-25 广东绿百多生物开发有限公司 Method for controlling bacterial pollution in chlorella culture by using bdellovibrio bacteriovorus
MX2020008932A (en) 2018-02-27 2020-10-01 Univ Pennsylvania NOVEL ADENO ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS HAVING REDUCED DEAMYDATION OF THE CAPSID AND USES THEREOF.
EP3767629A4 (en) * 2018-03-16 2022-01-19 KOTAI Biotechnologies, Inc. EFFICIENT GROUPING OF IMMUNOLOGICAL ENTITIES
JP6500144B1 (en) * 2018-03-28 2019-04-10 Ｋｏｔａｉバイオテクノロジーズ株式会社 Efficient clustering of immune entities
CN109035229B (en) * 2018-07-18 2022-02-18 河南牧业经济学院 Automatic evaluation method for cow body condition based on Fourier descriptor
EP3837692A4 (en) * 2018-08-15 2022-07-06 Zymergen, Inc. Bioreachable prediction tool with biological sequence selection
KR20210071017A (en) 2018-10-01 2021-06-15 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Compositions useful for treating GM1 gangliosidosis
US11699094B2 (en) * 2018-10-31 2023-07-11 Salesforce, Inc. Automatic feature selection and model generation for linear models
JP7236253B2 (en) * 2018-11-07 2023-03-09 合同会社Ｈ．Ｕ．グループ中央研究所 Information processing method and learning model
CN113302290A (en) 2018-11-16 2021-08-24 编码治疗公司 Compositions and methods for treating Wilson's disease
EP4269579A3 (en) 2019-01-04 2024-01-24 Ultragenyx Pharmaceutical Inc. Gene therapy constructs for treating wilson disease
AU2020229772A1 (en) 2019-02-26 2021-08-26 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of krabbe disease
WO2020180424A1 (en) 2019-03-04 2020-09-10 Iocurrents, Inc. Data compression and communication using machine learning
US11288582B2 (en) 2019-03-29 2022-03-29 Rovi Guides, Inc. Systems and methods for providing media content recommendations
CA3134379A1 (en) 2019-04-29 2020-11-05 Kalyani NAMBIAR Novel aav capsids and compositions containing same
CN111040031B (en) * 2019-12-13 2020-11-03 中国农业科学院兰州兽医研究所 ScFv antibody for resisting African swine fever virus and preparation method thereof
EP4096721A1 (en) 2020-02-02 2022-12-07 The Trustees of The University of Pennsylvania Compositions useful for treating gm1 gangliosidosis
MX2022014245A (en) 2020-05-12 2023-02-22 Univ Pennsylvania Compositions useful in treatment of krabbe disease.
CN111560069B (en) * 2020-05-15 2021-07-02 中国农业科学院兰州兽医研究所 A kind of single-chain antibody against African swine fever virus and its preparation method and use
US12435129B2 (en) 2020-07-23 2025-10-07 Othair Prothena Limited Anti-Aβ antibodies
IL300410A (en) 2020-08-14 2023-04-01 Univ Pennsylvania Novel aav capsids and compositions containing same
EP4225926A1 (en) 2020-10-07 2023-08-16 RegenxBio Inc. Gene therapy for ocular manifestations of cln2 disease
KR20230118075A (en) 2020-10-09 2023-08-10 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 Compositions and methods for the treatment of Fabry disease
AU2021369793A1 (en) 2020-10-29 2023-06-08 The Trustees Of The University Of Pennsylvania Aav capsids and compositions containing same
MX2023008826A (en) 2021-02-01 2023-09-15 Regenxbio Inc Gene therapy for neuronal ceroid lipofuscinoses.
CN113185607B (en) * 2021-03-22 2022-05-17 华南农业大学 A kind of preparation method of polyvalent avian adenovirus egg yolk antibody
TW202309066A (en) 2021-04-27 2023-03-01 賓州大學委員會 Porcine-derived adeno-associated virus capsids and uses thereof
WO2023047557A1 (en) 2021-09-27 2023-03-30 国立大学法人東北大学 Protein design method via machine learning
US20240384298A1 (en) 2021-10-02 2024-11-21 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
WO2023102517A1 (en) 2021-12-02 2023-06-08 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
US20250144243A1 (en) 2022-01-25 2025-05-08 The Trustees Of The University Of Pennsylvania Aav capsids for improved heart transduction and detargeting of liver
WO2023240236A1 (en) 2022-06-10 2023-12-14 Voyager Therapeutics, Inc. Compositions and methods for the treatment of spinal muscular atrophy related disorders
WO2024015966A2 (en) 2022-07-15 2024-01-18 The Trustees Of The University Of Pennsylvania Recombinant aav having aav clade d and clade e capsids and compositions containing same
US11861732B1 (en) * 2022-07-27 2024-01-02 Intuit Inc. Industry-profile service for fraud detection
CN115331728B (en) * 2022-08-12 2023-06-30 杭州力文所生物科技有限公司 A stable folded disulfide bond-rich polypeptide design method and its electronic device
WO2024105638A1 (en) 2022-11-18 2024-05-23 Jcr Pharmaceuticals Co., Ltd. Recombinant aav vectors and methods for treatment of hunter syndrome
EP4625420A1 (en) 2022-12-06 2025-10-01 RevolKa Ltd. Antibody design method through machine learning
WO2024241176A1 (en) 2023-05-24 2024-11-28 Jcr Pharmaceuticals Co., Ltd. Recombinant aav vectors and methods for treatment of diseases with central nervous system disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075129A2 (en) * 2002-03-01 2003-09-12 Maxygen, Inc. Methods, systems, and software for identifying functional bio-molecules

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5843708A (en) * 1988-01-05 1998-12-01 Ciba-Geigy Corporation Chimeric antibodies
GB2276169A (en) 1990-07-05 1994-09-21 Celltech Ltd Antibodies specific for carcinoembryonic antigen
US5681702A (en) 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US20020048772A1 (en) * 2000-02-10 2002-04-25 Dahiyat Bassil I. Protein design automation for protein libraries
WO2002005146A2 (en) * 2000-07-10 2002-01-17 Xencor, Inc. Method for disigning protein libraries with altered immunogenicity
US7117096B2 (en) * 2001-04-17 2006-10-03 Abmaxis, Inc. Structure-based selection and affinity maturation of antibody library
US7747391B2 (en) * 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) * 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US8005620B2 (en) * 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
EP1660970A4 (en) 2003-08-01 2007-02-14 Dna Twopointo Inc SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS
JP2006133755A (en) * 2004-10-07 2006-05-25 Pentax Corp Zoom lens system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075129A2 (en) * 2002-03-01 2003-09-12 Maxygen, Inc. Methods, systems, and software for identifying functional bio-molecules

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C GUSTAFSSON, S GOVINDARAJAN AND J MINSHULL: "Putting engineering back into protein engineering: bioinformatic approaches to catalyst design", CURRENT OPINION IN BIOTECHNOLOGY, vol. 14, no. 4, August 2003 (2003-08-01), pages 366 - 370, XP002411814 *
C GUSTAFSSON, S GOVINDARAJAN, R EMIG: "Exploration of sequence space for protein engineering", JOURNAL OF MOLECULAR RECOGNITION, vol. 14, no. 5, 15 October 2001 (2001-10-15), pages 308 - 314, XP002411815 *
FOX R ET AL: "Optimizing the search algorithm for protein engineering by directed evolution", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 16, no. 8, 1 August 2003 (2003-08-01), pages 589 - 597, XP002340574, ISSN: 0269-2139 *
HAYES R J ET AL: "Combining computational and experimental screening for rapid optimization of protein properties", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 99, no. 25, 10 December 2002 (2002-12-10), pages 15926 - 15931, XP002340572, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
US20110166844A1 (en) 2011-07-07
EP1660970A2 (en) 2006-05-31
WO2005013090A3 (en) 2006-04-13
WO2005012877A2 (en) 2005-02-10
US20140032186A1 (en) 2014-01-30
US20080050357A1 (en) 2008-02-28
WO2005013090A2 (en) 2005-02-10
US8412461B2 (en) 2013-04-02
EP2434420A2 (en) 2012-03-28
WO2005012877A3 (en) 2006-04-06
EP2434420A3 (en) 2012-07-25

Similar Documents

Publication Publication Date Title
EP1660970A4 (en) SYSTEMS AND METHODS FOR ENGINEERING BIOPOLYMERS
EP1660018A4 (en) SYSTEMS AND METHODS FOR ELECTROPULVERIZATION
EP1534125A4 (en) BRAIN-MACHINE INTERFACE SYSTEMS AND RELATED METHODS
EP1620676A4 (en) LIGHTING METHODS AND SYSTEMS
EP1839285A4 (en) SYSTEMS AND METHODS FOR MONITORING ARTICLES
EP1620843A4 (en) METHODS AND SYSTEMS FOR LIGHTING TILES
EP1488316A4 (en) SYSTEMS AND METHODS FOR IMPROVING THE SECURITY OF ELECTRONIC COMMUNICATIONS
EP1615513A4 (en) SYSTEMS AND METHODS FOR BETTER GARMENT ADJUSTMENT
EP1504429A4 (en) TRACKING SYSTEM AND ASSOCIATED PROCEDURE
EP1593231A4 (en) COLLABORATIVE COMMUNICATION SYSTEMS AND METHODS
EP1820101A4 (en) SYSTEMS AND METHODS FOR PROFILING MESSAGES
EP1540309A4 (en) IMPROVED TESTING SYSTEMS AND ASSOCIATED COMPONENTS
DE60205817D1 (en) Method for detecting and eliminating the memory effect
DK1478648T3 (en) PHOSPHORUS RELATIONS AND APPLICATIONS THEREOF
EP1692282A4 (en) IMPROVED PROTEIN EXPRESSION SYSTEMS
NO20032220D0 (en) Löfteverktöy II and method for using the same
EP1661047A4 (en) SYSTEMS AND METHODS FOR AUTOMATED COMPUTER ASSISTANCE
EP1933795A4 (en) IMPROVED METHODS AND SYSTEMS FOR MONITORING SURGICAL ARTICLES
EP1799232A4 (en) SELF-GELIFYING ALGINATE SYSTEMS AND USES THEREOF
DE60212580D1 (en) Location system and method
NO20042376L (en) Soil cleaning systems and methods
EP1514544A4 (en) HYPO-ALLERGENIC
DE50310178D1 (en) Stereo microscopy and stereo microscopy system
NO20055568D0 (en) Substituted 1,4-diazepines and uses thereof
DE60310145D1 (en) Wide angle observation system and procedures

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20060301

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101AFI20060703BHEP

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/00 20060101ALI20061219BHEP

Ipc: G06F 19/00 20060101AFI20061219BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070112

17Q First examination report despatched

Effective date: 20071001

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090203